Adjuvant endocrine therapies for postmenopausal women with early breast cancer: Standards and not
- 31 December 2005
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 14 (6) , 555-563
- https://doi.org/10.1016/j.breast.2005.08.017
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose LevelsBMJ, 1973
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATSReproduction, 1967
- Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted TriphenylethylenesNature, 1966
- V. Contributions to the physiology of mammalian reproduction. Part I.—The œstrous cycle in the dog. Part II.—The ovary as an organ of internal secretionPhilosophical Transactions of the Royal Society of London. Series B, Containing Papers of a Biological Character, 1906
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.The Lancet, 1896